A review of recent guidelines provides practical considerations for appropriate prescribing and deprescribing in older cardiovascular patients to balance medication benefits and harms.
How should medication regimens be managed to achieve appropriate polypharmacy in older cardiovascular patients?
Medication regimens in older cardiovascular patients require individualization and ongoing dialogue to balance proven benefits with the risks of polypharmacy.
BACKGROUND: Polypharmacy in older adults leads to increased risks of side effects and drug-drug interactions, affecting their health outcomes and quality of life. Deprescribing, the act of simplifying medication regimens, is challenging due to the lack of consensus guidelines. HYPOTHESIS: To offer some guidance on managing medication regimens for older cardiovascular patients. METHODS: We reviewed the most recent pertinent guidelines and literature. RESULTS: This review provides practical considerations for appropriate prescribing in the older population with cardiovascular disease in order to strike a balance between unnecessary or harmful medications and therapies with proven long-term benefits. CONCLUSION: On-going dialogue between healthcare providers and patients allows close monitoring of medication effectiveness and prevention of side effects. Medication regimens require individualization, as patients' goals of care change with advancing age.
Moulder et al. (Wed,) conducted a review in Cardiovascular disease in older adults. Appropriate prescribing and deprescribing was evaluated. A review of recent guidelines provides practical considerations for appropriate prescribing and deprescribing in older cardiovascular patients to balance medication benefits and harms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: